AdaptHealth Corp.
NASDAQ:AHCOMedical - Devices
+$0.01 today
- Market cap
- $1.01B
- Beta
- 1.46
- P/E (TTM)
- -16.3
- EPS (TTM)
- -$0.59
Volume 1.54M
Average 1.38M
AHCO EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
AdaptHealth Corp.NASDAQ: AHCO
EBITDA · Q1 FY2026 · quarter ended Apr 2026
EBITDA growth accelerates
Q1 FY2026 EBITDA of $122.79M rose 0.1% year over year, ahead of the -25.4% change in trailing-twelve-month EBITDA. Sequentially, it rose 412.6% from the prior quarter. Over 3 fiscal years it compounded at -7.2% a year.
Context
- EBITDA amounted to 15.5% of revenue in FY2025, down 3.7 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 5 analysts of $466.49M (-7.4%) for the fiscal year ending Dec 2026, a step up from the -19.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterApr 2026
- $122.79M+412.6% QoQ
- Last fiscal yearDec 2025
- $503.64M-19.8% YoY
- LTMApr 2026
- $462.48M-25.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +0.1% | -20.9% | -21.0 pp |
| 1 year | -19.8% | -7.4% | +12.4 pp |
| 3-year CAGR | -7.2% | -2.2% | +5.0 pp |
| 5-year CAGR | +5.9% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 503.64M USD
- Year-over-year change
- -19.8%
- 4-year CAGR
- -1.9%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 503.64M | -19.8% |
| FY2024 | 2024-12-31 | 628.02M | +467.1% |
| FY2023 | 2023-12-31 | (171.09M) | -127.1% |
| FY2022 | 2022-12-31 | 630.76M | +15.9% |
| FY2021 | 2021-12-31 | 544.21M | — |
EBITDA vs competitors
How AHCO compares with its peers on the latest reported figures
- AHCO's LTM Apr 2026 EBITDA of $462.48M is the 2nd highest of the 9 companies compared; the peer median is $20.32M.
- Its year-over-year change of -25.4% is the lowest of 9, against a peer median of +23.7%.
- EBITDA amounts to 16.2% of revenue for AHCO, versus a peer median of 18.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.17B | +12.7% | +16.5% | 38.3% | |
| LTM Apr 2026 | $462.48M | -25.4% | -7.2% | 16.2% | |
| LTM Jun 2026 | $83.09M | -4.7% | — | 9.2% | |
| LTM Mar 2026 | $53.03M | +28.1% | +27.6% | 18.5% | |
| LTM Mar 2026 | $25.86M | +21.2% | +19.2% | 18.2% | |
| LTM Mar 2026 | $14.78M | +39.5% | +46.7% | 20.6% | |
| LTM Mar 2026 | -$5.23M | +26.2% | — | 1.5% | |
| LTM Mar 2026 | -$63.5M | +7.9% | — | 57.6% | |
| LTM Mar 2026 | -$71.9M | +52.3% | — | 7.0% | |
| Peer median (excluding AHCO) | $20.32M | +23.7% | +23.4% | 18.3% | |
Competitors are the stored peer set for AHCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.45B | 2.97B | 3.2B | 3.26B | 3.24B |
| Cost of Revenue | 2.01B | 2.55B | 2.52B | 2.58B | 2.68B |
| Gross Profit | 445.61M | 417.43M | 681.77M | 681.09M | 568.56M |
| Gross Margin | 18.2% | 14.1% | 21.3% | 20.9% | 17.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 167.51M | 162.13M | 190.09M | 359.24M | 382.29M |
| Operating Expenses | 220.01M | 227.02M | 1.28B | 417.36M | 382.29M |
| Depreciation & Amortization | 258.05M | 423.44M | 420.59M | 365.33M | 413.04M |
| EBITDA | 544.21M | 630.76M | (171.09M) | 628.02M | 503.64M |
| EBITDA Margin | 22.2% | 21.2% | -5.3% | 19.3% | 15.5% |
| Operating Income | 225.61M | 190.41M | (598.4M) | 263.73M | 186.27M |
| Operating Margin | 9.2% | 6.4% | -18.7% | 8.1% | 5.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 95.2M | 109.41M | 130.3M | 126.67M | 105.75M |
| Other Income / Expenses | (34.65M) | (92.51M) | (125.38M) | (127.71M) | (201.42M) |
| Income Before Tax | 190.96M | 97.9M | (723.78M) | 136.02M | (15.15M) |
| Pre-Tax Margin | 7.8% | 3.3% | -22.6% | 4.2% | -0.5% |
| Income Tax Expense | 32.81M | 24.77M | (49M) | 41.24M | 50.88M |
| Net Income | 156.18M | 69.32M | (678.9M) | 90.42M | (70.79M) |
| Net Margin | 6.4% | 2.3% | -21.2% | 2.8% | -2.2% |
| EPS (Basic) | 1.12 | 0.52 | (5.32) | 0.62 | (0.52) |
| EPS (Diluted) | 0.67 | 0.50 | (5.31) | 0.61 | (0.52) |
| Weighted Avg Shares | 126.31M | 134.18M | 134.16M | 133.76M | 135.15M |
| Weighted Avg Shares (Diluted) | 133.03M | 138.99M | 134.42M | 135.53M | 135.15M |
AdaptHealth Corp.
NASDAQ:AHCO
Intrinsic Alpha fair value
Locked
Current Price
$7.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.